Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients;Evaluación de la administración de vancomicina y las concentraciones séricas posteriores en pacientes pediátricos

Annals of Pharmacotherapy

Volumn 45, Issue 5, 2011, Pages 582-589

  Eiland, Lea S ^a   English, Thomas M ^b   Eiland III, Edward H ^c  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c HUNTSVILLE HOSPITAL   (United States)

Author keywords

Drug monitoring; Pediatrics; Pharmacokinetics; Vancomycin

Indexed keywords

VANCOMYCIN;

ABSCESS; ADULT; ARTICLE; BACTERIAL ARTHRITIS; CELLULITIS; CHILD; CREATININE CLEARANCE; DOSIMETRY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG MONITORING; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INFANT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MENINGITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; OSTEOMYELITIS; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG DOSAGE CALCULATIONS; DRUG MONITORING; FEMALE; HUMANS; INFANT; INFECTION; MALE; PEDIATRICS; RETROSPECTIVE STUDIES; VANCOMYCIN;

EID: 79957606863     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P588     Document Type: Article

References (17)

1. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009;66:82-98. Erratum in: Am J Health Syst Pharm 2009;66:887.
2. Spears RL, Koch R. The use of vancomycin in pediatrics. Antibiot Annu 1959;1960:798-803.
3. Schaad UB, McCracken GH Jr, Nelson JD. Clinical pharmacology and efficacy of vancomycin in pediatric patients. J Pediatr 1980;96:119-26.
4. Taketomo CK, Hodding JH, Kraus DM. Pediatric dosing handbook. 15th ed. Hudson, OH: Lexi-Comp, 2009-2009.
5. Glover ML, Cole E, Wolfsdorf J. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function. J Crit Care 2000;15:1- 4.
6. Piro CC, Crossno CL, Collier A, Ho R, Koyama T, Frangoul H. Initial vancomycin dosing in pediatric oncology and stem cell transplant patients. J Pediatr Hematol Oncol 2009;31:3-7.
7. Benner KW, Worthington MA, Kimberlin DW, Hill K, Buckley K, Tolif NM. Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review. J Pediatr Pharmacol Ther 2009; 14:86-93.
8. Chang D, Liem L, Malogolowkin M. A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric cancer patients. Pediatr Infect Dis J 1994;13:969-74.
9. Chang D. Influence of malignancy on the pharmacokinetics of vancomycin in infants and children. Pediatr Infect Dis J 1995;14:667-73.
10. Miles MV, Li L, Lakkis H, Youngblood J, McGinnis P. Special considerations for monitoring vancomycin concentrations in pediatric patients. Ther Drug Monit 1997;19:265-70.
11. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillinresistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011;52:1-38.
12. Lodise TP, Graves J, Evans A, et al. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008;52:3315-20.
13. Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 2006;166:2138- 44.
14. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rates in infants, children and adolescents. Pediatr Clin North Am 1987;34:571-90.
15. McCabe T, Davis G, Iocono J, Nelson C, Kuhn R. Evaluating the empiric dose of vancomycin in pediatric patients (abstract). J Pediatr Pharmacol Ther 2009;14:168.
16. Frymoyer A, Hersh AL, Benet LZ, Guglielmo BJ. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J 2009;28:398-402.
17. Lodise TP, Lomaestro B, Graves J, Drusano GL. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother 2008;52:1330-6.